186 related articles for article (PubMed ID: 6972419)
1. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants.
Moxon ER; Vaughn KA
J Infect Dis; 1981 Apr; 143(4):517-24. PubMed ID: 6972419
[TBL] [Abstract][Full Text] [Related]
2. Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats.
Zwahlen A; Winkelstein JA; Moxon ER
J Infect Dis; 1983 Sep; 148(3):385-94. PubMed ID: 6604759
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap.
Zwahlen A; Kroll JS; Rubin LG; Moxon ER
Microb Pathog; 1989 Sep; 7(3):225-35. PubMed ID: 2615636
[TBL] [Abstract][Full Text] [Related]
4. Comparative virulence of Haemophilus influenzae with a type b or type d capsule.
Roberts M; Stull TL; Smith AL
Infect Immun; 1981 May; 32(2):518-24. PubMed ID: 6972914
[TBL] [Abstract][Full Text] [Related]
5. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats.
Zwahlen A; Rubin LG; Moxon ER
Microb Pathog; 1986 Oct; 1(5):465-73. PubMed ID: 3509884
[TBL] [Abstract][Full Text] [Related]
6. Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence.
Moxon ER; Deich RA; Connelly C
J Clin Invest; 1984 Feb; 73(2):298-306. PubMed ID: 6607932
[TBL] [Abstract][Full Text] [Related]
7. Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae.
Moxon ER; Kroll JS
Vaccine; 1988 Apr; 6(2):113-5. PubMed ID: 3291448
[TBL] [Abstract][Full Text] [Related]
8. Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.
Cope LD; Yogev R; Mertsola J; Argyle JC; McCracken GH; Hansen EJ
Infect Immun; 1990 Jul; 58(7):2343-51. PubMed ID: 1694825
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the cell wall of Haemophilus influenzae type b by transformation with cloned DNA: association with attenuated virulence.
Zwahlen A; Rubin LG; Connelly CJ; Inzana TJ; Moxon ER
J Infect Dis; 1985 Sep; 152(3):485-92. PubMed ID: 3875666
[TBL] [Abstract][Full Text] [Related]
10. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
Yogev R; Moxon ER
J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
[TBL] [Abstract][Full Text] [Related]
11. Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae.
Weiser JN; Williams A; Moxon ER
Infect Immun; 1990 Oct; 58(10):3455-7. PubMed ID: 2401571
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of invasive Haemophilus influenzae type b disease.
Moxon ER
J Infect Dis; 1992 Jun; 165 Suppl 1():S77-81. PubMed ID: 1588186
[TBL] [Abstract][Full Text] [Related]
13. Differential complement resistance mediates virulence of Haemophilus influenzae type b.
Sutton A; Schneerson R; Kendall-Morris S; Robbins JB
Infect Immun; 1982 Jan; 35(1):95-104. PubMed ID: 6976328
[TBL] [Abstract][Full Text] [Related]
14. The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia.
Weller PF; Smith AL; Anderson P; Smith DH
J Infect Dis; 1977 Jan; 135(1):34-41. PubMed ID: 299866
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Haemophilus influenzae type b lipopolysaccharide to pathogenesis of infection.
Kaplan SL; Hawkins EP; Inzana TJ; Patrick CC; Mason EO
Microb Pathog; 1988 Jul; 5(1):55-62. PubMed ID: 3072463
[TBL] [Abstract][Full Text] [Related]
16. Complement-mediated serum activities against genetically defined capsular transformants of Haemophilus influenzae.
Swift AJ; Moxon ER; Zwahlen A; Winkelstein JA
Microb Pathog; 1991 Apr; 10(4):261-9. PubMed ID: 1895927
[TBL] [Abstract][Full Text] [Related]
17. Characterization of capsular genes in Haemophilus influenzae isolates from H. influenzae type b vaccine recipients.
Falla TJ; Crook DW; Anderson EC; Ward JI; Santosham M; Eskola J; Moxon ER
J Infect Dis; 1995 Apr; 171(4):1075-6. PubMed ID: 7706799
[No Abstract] [Full Text] [Related]
18. [PCR-based capsular typing of Haemophilus influenzae isolates non-typeable by agglutination].
Weltman G; Fossati MS; Correa C; Regueira M; Mollerach M
Rev Argent Microbiol; 2005; 37(4):199-202. PubMed ID: 16502640
[TBL] [Abstract][Full Text] [Related]
19. Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.
Kapogiannis BG; Satola S; Keyserling HL; Farley MM
Clin Infect Dis; 2005 Dec; 41(11):e97-103. PubMed ID: 16267724
[TBL] [Abstract][Full Text] [Related]
20. Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b.
Kroll JS; Moxon ER
J Bacteriol; 1988 Feb; 170(2):859-64. PubMed ID: 2828329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
